Medicare Program; Request for Nominations for Members for the Medicare Evidence Development & Coverage Advisory Committee; Correction, 63657 [2019-24934]
Download as PDF
<![CDATA[
Federal Register / Vol. 84, No. 222 / Monday, November 18, 2019 / Notices
program, known as the Voluntary
Prescription Drug Benefit Program. As
required by 42 CFR 423.32(a) and (b), a
Part D-eligible individual who wishes to
enroll in a Medicare prescription drug
plan (PDP) may enroll during the
enrollment periods specified in
§ 423.38, by completing an enrollment
form with the PDP, or enrolling through
other mechanisms CMS determines are
appropriate. Form Number: CMS–10718
(OMB control number: 0938–New);
Frequency: Yearly; Affected Public:
State, Local, or Tribal Governments;
Number of Respondents: 14,749,256;
Total Annual Responses: 14,749,256;
Total Annual Hours: 10,324,481. (For
policy questions regarding this
collection contact Deme Umo at (410)
786–8854.)
5. Type of Information Collection
Request: Revision with change of a
currently approved collection; Title of
Information Collection: Notice of Denial
of Medicare Prescription Drug Coverage;
Use: The purpose of this notice is to
provide information to enrollees when
prescription drug coverage has been
denied, in whole or in part, by their Part
D plans. The notice must be readable,
understandable, and state the specific
reasons for the denial. The notice must
also remind enrollees about their rights
and protections related to requests for
prescription drug coverage and include
an explanation of both the standard and
expedited redetermination processes
and the rest of the appeal process.
CMS requests approval of changes to
a currently approved collection under
section 1860D–4(g)(1) of the Social
Security Act which requires Part D plan
sponsors that deny prescription drug
coverage to provide a written notice of
the denial to the enrollee. The written
notice must include a statement, in
understandable language, of the reasons
for the denial and a description of the
appeals process.
Medicare beneficiaries who are
enrolled in a Part D plan will be
informed of adverse decisions related to
their prescription drug coverage and
their right to appeal these decisions.
The notice provides all ways that the
beneficiary can file an appeal under one
section. The Part D instructions have
also been revised to include a paragraph
informing providers that in the case that
a request for a coverage determination is
denied under Part B due to step therapy
requirements, a different notice should
be given.
This denial notice is primarily issued
to Part D plan enrollees (Medicare
beneficiaries) and is most commonly
sent to enrollees by mail. Relying on
electronic transmission of this notice to
beneficiaries is impractical. Plans are
VerDate Sep<11>2014
17:41 Nov 15, 2019
Jkt 250001
required by regulation to maintain a
website by which beneficiaries can
request an appeal. In this version of the
notice, website information is more
prominently displayed. Form Number:
CMS–10146 (OMB control number:
0938–0976); Frequency: Yearly; Affected
Public: State, Local, or Tribal
Governments; Number of Respondents:
525; Total Annual Responses:
2,887,866; Total Annual Hours: 721,967.
(For policy questions regarding this
collection contact Sara Klotz at (410)
786–1984.)
63657
1. On page 56193, second column,
third full paragraph, last line, the email
address ‘‘Leah.Cromwell@cms.hhs.gov’’
is corrected to read ‘‘Leah.Cromwell1@
cms.hhs.gov’’.
Dated: November 4, 2019.
Kate Goodrich.
Director, Center for Clinical Standards and
Quality, Chief Medical Officer, Centers for
Medicare & Medicaid Services.
[FR Doc. 2019–24934 Filed 11–15–19; 8:45 am]
BILLING CODE 4120–01–P
Dated: November 13, 2019.
William N. Parham, III,
Director, Paperwork Reduction Staff, Office
of Strategic Operations and Regulatory
Affairs.
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
[FR Doc. 2019–24930 Filed 11–15–19; 8:45 am]
BILLING CODE 4120–01–P
[Document Identifier CMS–10611, CMS–R–
282 and CMS–R–235]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Agency Information Collection
Activities: Submission for OMB
Review; Comment Request
Centers for Medicare & Medicaid
Services
[CMS–3392–CN]
Medicare Program; Request for
Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee;
Correction
Centers for Medicare &
Medicaid Services (CMS), HHS.
ACTION: Correction notice.
AGENCY:
This document corrects a
typographical error that appeared in the
notice published in the Federal Register
on October 21, 2019 entitled ‘‘Request
for Nominations for Members for the
Medicare Evidence Development &
Coverage Advisory Committee.’’
DATES: This correcting document is
effective on November 15, 2019.
FOR FURTHER INFORMATION CONTACT:
Leah Cromwell, (410) 786–2243.
SUPPLEMENTARY INFORMATION:
SUMMARY:
I. Background and Summary of Errors
In FR Doc. 2019–22947 of October 21,
2019 (84 FR 56193), there was a
typographical error that is identified in
the FOR FURTHER INFORMATION CONTACT
section.
On page 56193, we inadvertently
made a typographical error in the email
address of the Medicare Evidence
Development & Coverage Advisory
Committee (MEDCAC) coordinator.
II. Correction of Errors
In FR Doc. 2019–22947 of October 21,
2019 (84 FR 56193), make the following
corrections:
PO 00000
Frm 00053
Fmt 4703
Sfmt 4703
Centers for Medicare & Medicaid
Services
Centers for Medicare &
Medicaid Services, HHS.
ACTION: Notice.
AGENCY:
The Centers for Medicare &
Medicaid Services (CMS) is announcing
an opportunity for the public to
comment on CMS’ intention to collect
information from the public. Under the
Paperwork Reduction Act of 1995
(PRA), federal agencies are required to
publish notice in the Federal Register
concerning each proposed collection of
information, including each proposed
extension or reinstatement of an existing
collection of information, and to allow
a second opportunity for public
comment on the notice. Interested
persons are invited to send comments
regarding the burden estimate or any
other aspect of this collection of
information, including the necessity and
utility of the proposed information
collection for the proper performance of
the agency’s functions, the accuracy of
the estimated burden, ways to enhance
the quality, utility, and clarity of the
information to be collected, and the use
of automated collection techniques or
other forms of information technology to
minimize the information collection
burden.
SUMMARY:
Comments on the collection(s) of
information must be received by the
OMB desk officer by December 18, 2019.
ADDRESSES: When commenting on the
proposed information collections,
please reference the document identifier
or OMB control number. To be assured
consideration, comments and
recommendations must be received by
the OMB desk officer via one of the
DATES:
E:\FR\FM\18NON1.SGM
18NON1
]]>Agencies
[Federal Register Volume 84, Number 222 (Monday, November 18, 2019)]
[Notices]
[Page 63657]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2019-24934]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
Centers for Medicare & Medicaid Services
[CMS-3392-CN]
Medicare Program; Request for Nominations for Members for the
Medicare Evidence Development & Coverage Advisory Committee; Correction
AGENCY: Centers for Medicare & Medicaid Services (CMS), HHS.
ACTION: Correction notice.
-----------------------------------------------------------------------
SUMMARY: This document corrects a typographical error that appeared in
the notice published in the Federal Register on October 21, 2019
entitled ``Request for Nominations for Members for the Medicare
Evidence Development & Coverage Advisory Committee.''
DATES: This correcting document is effective on November 15, 2019.
FOR FURTHER INFORMATION CONTACT: Leah Cromwell, (410) 786-2243.
SUPPLEMENTARY INFORMATION:
I. Background and Summary of Errors
In FR Doc. 2019-22947 of October 21, 2019 (84 FR 56193), there was
a typographical error that is identified in the For Further Information
Contact section.
On page 56193, we inadvertently made a typographical error in the
email address of the Medicare Evidence Development & Coverage Advisory
Committee (MEDCAC) coordinator.
II. Correction of Errors
In FR Doc. 2019-22947 of October 21, 2019 (84 FR 56193), make the
following corrections:
1. On page 56193, second column, third full paragraph, last line,
the email address ``[email protected]'' is corrected to read
``[email protected]''.
Dated: November 4, 2019.
Kate Goodrich.
Director, Center for Clinical Standards and Quality, Chief Medical
Officer, Centers for Medicare & Medicaid Services.
[FR Doc. 2019-24934 Filed 11-15-19; 8:45 am]
BILLING CODE 4120-01-P
